US District Court Judge Curtis Joyner on Friday denied Johnson & Johnson’s (J&J) attempt to scuttle a lawsuit brought by Pfizer over its failure to gain market penetration for its Remicade (infliximab) biosimilar Inflectra (infliximab-dyyb).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,